Back to Journals » OncoTargets and Therapy » Volume 7

Review

Profile of trebananib (AMG386) and its potential in the treatment of ovarian cancer

       
Total article views   HTML views PDF downloads Totals
11,973 Dovepress* 9,506+ 1,547 11,053
PubMed Central* 2,467 462 2,929
Totals 11,973 2,009 13,982
*Since 4 October 2014
+Since July 2016

View citations on PubMed Central and Google Scholar